Working together with laboratories, Thermo Fisher Scientific played a critical role in helping to solve the world’s greatest challenges during the COVID‑19 pandemic. As a leader in the industry, we will continue to be here for you—delivering trusted molecular diagnostic solutions that help you guide effective patient outcomes.
Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices.
While traditional methods, such as culture, continue to have an important role in diagnosis of infectious diseases, PCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.
Explore the resources below to learn more about the role molecular testing can serve in patient management and care decisions.
In this 3-part educational series hosted in collaboration with Arizona State University, leading national experts in the chosen topics tackle the important challenges surrounding when, how, and why to use diagnostics to improve the current healthcare system.
Molecular diagnostic testing for viral hepatitis can be used to confirm hepatitis infection when serology results are unclear, and to monitor viral load levels.
A compilation of informative interviews with key medical experts, this is intended to aid lab professionals and clinicians working in all types of laboratories to better understand the clinical value of molecular testing.
This comprehensive HIV learning guide is offered with case studies in four modules and is edited by HIV healthcare experts from Senegal, Nigeria, India, and Brazil.
PGx is a core element of precision medicine and is designed to improve the individual’s response to medication by assessing drug-compatibilities with the person’s genomic profile.
An overview of the many potential causes of infectious gastroenteritis and why molecular testing is critical to help differentiate.
What is clinical utility? Clinical utility defines the likelihood of the test’s results to inform and support clinical decisions that improve patient outcomes. Learn more in our latest blog.
This article summarizes highlights learned from syndromic panels for RTIs, UTIs, STIs, and vaginal and GI infections, and antimicrobial resistance markers.
Read why laboratories newly equipped with MDx infrastructure may be in an advantageous position to expand testing menus to include infectious diseases beyond SARS-CoV-2.